ScholarIQanswers from OpenAlex & ORCID
Michael B. Maris
ResearcherPublications, citations & collaboration network
Michael B. Maris is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael B. Maris have?
ScholarIQindexed works
Michael B. Maris has 242 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael B. Maris have?
ScholarIQcitation count
Michael B. Maris has 16,929 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael B. Maris?
ScholarIQh-index
Michael B. Maris has an h-index of 60 in OpenAlex.
What is the i10-index of Michael B. Maris?
ScholarIQi10-index
Michael B. Maris has an i10-index of 131 in OpenAlex.
What is the OpenAlex record for Michael B. Maris?
ScholarIQopenalex
The OpenAlex for Michael B. Maris is on the source record.
What are the most-cited papers on Michael B. Maris?
ScholarIQmost cited works
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer, Georg‐Nikolaus Franke, Ginna G. Laport, Thomas R. Chauncey, Edward Agura, Richard T. Maziarz, Amelia Langston, Parameswaran Hari, Michael A. Pulsipher, Wolfgang Bethge, Firoozeh Sahebi, Benedetto Bruno, Michael B. Maris, Andrew M. Yeager, Finn Bo Petersen, Lars L. Vindeløv, Peter A. McSweeney, Kai Hübel, Marco Mielcarek, George E. Georges, Dietger Niederwieser, Karl G. Blume, David G. Maloney, Rainer Storb
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
Rainer Storb, Boglarka Gyurkocza, Barry E. Storer, Mohamed L. Sorror, Karl G. Blume, Dietger Niederwieser, Thomas R. Chauncey, Michael A. Pulsipher, Finn Bo Petersen, Firoozeh Sahebi, Edward Agura, Parameswaran Hari, Benedetto Bruno, Peter A. McSweeney, Michael B. Maris, Richard T. Maziarz, Amelia Langston, Wolfgang Bethge, Lars L. Vindeløv, Georg‐Nikolaus Franke, Ginna G. Laport, Andrew M. Yeager, Kai Hübel, H. Joachim Deeg, George E. Georges, Mary E.D. Flowers, Paul J. Martin, Marco Mielcarek, Ann E. Woolfrey, David G. Maloney, Brenda M. Sandmaier
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P. Steensma, Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji, Jay Yang, Andrew M. Brunner, Hetty E. Carraway, Lionel Adès, Aref Al‐Kali, Juan Manuel Alonso‐Domínguez, Ana Alfonso Piérola, Catherine C. Coombs, H. Joachim Deeg, Ian W. Flinn, James M. Foran, Guillermo Garcia‐Manero, Michael B. Maris, Malgorzata McMasters, Jean‐Baptiste Micol, Jaime Pérez de Oteyza, Felicitas Thol, Eunice S. Wang, Justin M. Watts, Justin Taylor, Richard M. Stone, Vikram Gourineni, Alyssa J. Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker